1. Home
  2. BLCO vs STEP Comparison

BLCO vs STEP Comparison

Compare BLCO & STEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLCO
  • STEP
  • Stock Information
  • Founded
  • BLCO 1853
  • STEP 2007
  • Country
  • BLCO Canada
  • STEP United States
  • Employees
  • BLCO N/A
  • STEP N/A
  • Industry
  • BLCO Ophthalmic Goods
  • STEP Finance/Investors Services
  • Sector
  • BLCO Health Care
  • STEP Finance
  • Exchange
  • BLCO Nasdaq
  • STEP Nasdaq
  • Market Cap
  • BLCO 5.6B
  • STEP 4.6B
  • IPO Year
  • BLCO 2022
  • STEP 2020
  • Fundamental
  • Price
  • BLCO $14.14
  • STEP $51.98
  • Analyst Decision
  • BLCO Hold
  • STEP Buy
  • Analyst Count
  • BLCO 11
  • STEP 7
  • Target Price
  • BLCO $19.10
  • STEP $69.21
  • AVG Volume (30 Days)
  • BLCO 578.8K
  • STEP 729.3K
  • Earning Date
  • BLCO 04-30-2025
  • STEP 05-22-2025
  • Dividend Yield
  • BLCO N/A
  • STEP 1.86%
  • EPS Growth
  • BLCO N/A
  • STEP N/A
  • EPS
  • BLCO N/A
  • STEP N/A
  • Revenue
  • BLCO $4,791,000,000.00
  • STEP $1,153,911,000.00
  • Revenue This Year
  • BLCO $6.53
  • STEP $27.92
  • Revenue Next Year
  • BLCO $5.64
  • STEP $21.82
  • P/E Ratio
  • BLCO N/A
  • STEP N/A
  • Revenue Growth
  • BLCO 15.56
  • STEP 118.88
  • 52 Week Low
  • BLCO $13.16
  • STEP $33.92
  • 52 Week High
  • BLCO $21.69
  • STEP $70.38
  • Technical
  • Relative Strength Index (RSI)
  • BLCO 26.70
  • STEP 43.75
  • Support Level
  • BLCO $15.23
  • STEP $53.71
  • Resistance Level
  • BLCO $15.77
  • STEP $57.81
  • Average True Range (ATR)
  • BLCO 0.44
  • STEP 1.92
  • MACD
  • BLCO -0.05
  • STEP 0.32
  • Stochastic Oscillator
  • BLCO 11.82
  • STEP 58.46

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

About STEP StepStone Group Inc.

StepStone Group Inc operates as a fully integrated private markets solution provider. The company provides customized investment solutions and advisory and data services. It provides investment solutions in the areas of private equity, real estate, private debt, and infrastructure and real assets. The company consists of a single operating segment and a single reportable segment for accounting and financial reporting purposes.

Share on Social Networks: